The Cytokine Network

by
Format: Hardcover
Pub. Date: 2000-04-06
Publisher(s): Oxford University Press
Availability: This title is currently not available.
List Price: $137.60

Rent Textbook

Select for Price
There was a problem. Please try again later.

New Textbook

We're Sorry
Sold Out

Used Textbook

We're Sorry
Sold Out

eTextbook

We're Sorry
Not Available

Summary

Cytokines are soluble mediators of intercellular communication. They contribute to a chemical signalling language that regulates development, tissue repair, haemopoiesis, inflammation and the immune response. Potent cytokine polypepides have pleiotropic activities and functional redundancy.They act in a complex network where one cytokine can influence the production of, and response to, many other cytokines. In the past five years, this bewildering array of more than 100 effector molecules and associated cell surface receptors has been simplified by study of cytokine and cytokinereceptor structure; elucidation of convergent intracellular signalling pathways; and molecular genetics, and targeted gene disruption to 'knock-out' production of individual cytokines in mice. It is also now clear that the pathophysiology of infectious, autoimmune and malignant disease can bepartially explained by the induction of cytokines and the subsequent cellular response. Viral homologues exist for many cytokines and receptors and genetic variations in cytokine production may influence response to pathogenic stimuli. Cytokine and cytokine antagonists have shown therapeuticpotential in a number of chronic and acute diseases. The Cytokine Network: Frontiers in Molecular Biology is not a survey of individual cytokines, but guides the reader through the latest research on the cytokine network as a whole covering genomics, signalling pathways, control of the immuneresponse, and therapeutics.

Table of Contents

List of contributors
xiii
Abbreviations xv
A genomics approach to cytokine discovery
1(19)
Craig A. Rosen
Michael R. Fannon
Gianni Garotta
Steven M. Ruben
Introduction
1(1)
cDNA-based methods for high-throughput gene discovery
1(6)
Data analysis
2(2)
Selection method for candidate genes
4(1)
Case study of database analysis to identify a tissue-specific cytokine
4(3)
Identification of new chemokine family members
7(2)
MPIF-1, a chemokine with stem cell inhibitory activity
7(2)
Expansion of the TNF/TNF receptor repertoire
9(4)
Database approaches toward high-throughput discovery of novel cytokines
13(7)
References
16(4)
Cytokine signal transduction
20(29)
Keats Nelms
Introduction
20(1)
Initiation of signal transduction by cytokine receptors
20(2)
Cytokine receptors
20(1)
Activation of receptor-associated tyrosine kinases
21(1)
Cytokine signalling pathways
22(17)
The Ras/mitogen activated protein kinase pathway
24(5)
The phosphoinositide-3-kinase pathway
29(3)
Pathways leading to gene activation
32(5)
Pathways leading to cell death
37(2)
Modulation of signal transduction pathways
39(3)
Negative regulation of kinase activation
39(1)
Negative regulation of the Ras/MAPK pathway
39(2)
Regulation of signal transduction by phosphatases
41(1)
Conclusion
42(7)
References
43(6)
Cytokine networks
49(22)
Fionula M. Brennan
Marc Feldmann
Introduction
49(1)
Cloning cytokines and evaluating their functions
49(1)
Analysis of cytokine activity in vivo
50(2)
Cytokine transgenic mice
50(1)
Cytokine knock-out mice
51(1)
Regulation of cytokines in rheumatoid arthritis
52(4)
What are the upstream cytokine inducers of the cytokine network in RA?
53(1)
Cytokine interactions in animal models of arthritis
54(1)
What regulates the cytokine network?
55(1)
Immunoregulatory cytokines
56(5)
Interleukin 10
56(1)
Interleukin 11
57(2)
TGF-β
59(1)
Interleukin 4
60(1)
Cytokine inhibitors
61(1)
What maintains the cytokine network in rheumatoid arthritis?
62(1)
Demonstration of cytokine network interactions in vivo
63(1)
Immunotherapy of RA
63(1)
Concluding remarks
64(7)
References
64(7)
Cytokines and the Th1/Th2 paradigm
71(32)
Sergio Romagnani
Definitions of Th1 and Th2 cells
71(2)
Nature of Th1/Th2-polarizing signals
73(6)
Site of antigen presentation
73(1)
Type of APC
73(1)
Co-stimulatory molecules
74(1)
Properties of the immunogen
75(1)
Dose of antigen
75(1)
Peptide density and binding affinity
75(1)
Cytokines
76(2)
Hormones
78(1)
Role of the genetic background in the Th1/Th2 development
79(1)
Intracellular signalling for Th1/Th2 development
79(3)
Intracellular signalling for Th2 development
80(1)
Intracellular signalling for Th1 development
80(2)
Cross-regulatory activity of Th1 and Th2 cytokines
82(1)
The Th1/Th2 paradigm in human diseases
83(9)
Transplantation rejection and tolerance
83(1)
Successful pregnancy and unexplained recurrent abortions
84(1)
Allergic disorders
84(2)
Autoimmune disorders
86(3)
Chronic inflammatory gastrointestinal disorders
89(2)
Progression of HIV infection
91(1)
Conclusion remarks
92(11)
References
93(10)
Chemokines
103(23)
Alberto Mantovani
Silvano Sozzani
Introduction
103(1)
Structure and families
104(1)
Receptors and signal transduction
105(2)
Chemokine functions
107(1)
Regulation of chemokine production
107(1)
Regulation of receptor expression during activation and deactivation of mononuclear phagocytes
108(2)
Regulation of receptor expression: dendritic cells
110(1)
Pathology
111(15)
Polarized Th1 and Th2 responses
112(1)
Tumours as a paradigm for the in vivo function of chemokines
113(4)
References
117(9)
Cytokines and cytokine receptors encoded by viruses
126(26)
Julian A. Symons
Geoffrey L. Smith
Role of cytokines in antiviral defence
126(1)
Pox viruses and herpesviruses
126(1)
Cytokines encoded by viruses
127(7)
Viral growth factors
129(1)
Viral chemokines
130(2)
HHV-8 IL-6
132(1)
Viral IL-10 (vIL-10)
132(2)
HSV IL-17
134(1)
Cytokine receptors encoded by viruses
134(10)
Soluble cytokine receptors
134(9)
Viral membrane CKRs
143(1)
Conclusions and future prospects
144(8)
References
145(7)
Genetic variation in cytokines and relevance to inflammation and disease
152(22)
Gordon Duff
Introduction
152(1)
Cytokines as candidate genes
153(2)
TNF locus polymorphisms and the MHC
155(3)
TNF locus polymorphism and diseases
156(2)
The interleukin 1 gene cluster
158(2)
IL-1 locus polymorphisms and diseases
159(1)
Susceptibility or severity?
160(1)
IL-4 and IL-4R polymorphisms and diseases
160(1)
IL-6 gene polymorphism and diseases
161(1)
Il-10 gene polymorphism and diseases
162(1)
Chemokine receptor gene polymorphisms
162(1)
Conclusion
163(11)
References
164(10)
Therapeutic manipulation of the cytokine network
174(11)
Fran Balkwill
Introduction
174(1)
Recombinant cytokine therapy of cancer
174(5)
IFN-α therapy of malignant disease
175(1)
IFN-γ therapy of malignant disease
176(1)
TNF-α therapy of malignant disease
177(1)
IL-12 therapy of malignant disease
178(1)
The potential of cytokine antagonist therapy in cancer
179(2)
Inflammatory cytokines and cancer --- the case for cytokine antagonist therapy
180(1)
Other cytokine signalling targets
181(1)
Mechanisms of action of cytokine therapy in malignancy
181(1)
Future directions
182(2)
Local delivery
182(2)
The important of understanding the tumour cytokine network
184(1)
Sequential or combination biological therapy
184(1)
Summary
184(1)
References 185(6)
Index 191

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

Digital License

You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.

More details can be found here.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.